← Back to Search

Behavioural Intervention

Healthy Lifestyles for Bipolar Disorder (HL Trial)

N/A
Waitlist Available
Led By Sheri L Johnson, PhD
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
I have not gained or lost more than 11 pounds in the last 3 months.
I have access to a smartphone.
Must not have
Have you been diagnosed with Schizophrenia?
Timeline
Screening 2 weeks
Treatment 8 weeks
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the effects of two different healthy lifestyles on people with bipolar disorder. The trial will investigate the acceptability of time-restricted eating and the Mediterranean diet for those who are already taking

Who is the study for?
This trial is for individuals with bipolar disorder who are currently on medication. Participants will track their eating, sleep, and mood for two weeks before being randomly assigned to one of two healthy eating plans: time-restricted eating or the Mediterranean diet.
What is being tested?
The study aims to assess the acceptability and impact of time-restricted eating versus the Mediterranean diet on manic and depressive symptoms, as well as overall quality of life in people with bipolar disorder already receiving medication.
What are the potential side effects?
Since this trial focuses on dietary interventions rather than medications, side effects may include changes in weight, digestive discomfort or alterations in energy levels due to new eating patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently receiving treatment for bipolar disorder.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 2 weeks
Treatment ~ 8 weeks
Follow Up ~12 months
This trial's timeline: 2 weeks for screening, 8 weeks for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Adherence to Mediterranean Diet
Adherence to time-restricted eating
+6 more
Secondary study objectives
Daily emotional lability as assessed using ecological momentary assessment
Regularity of daily routines (Brief Social Rhythm Questionnaire)
Self-rated depression
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Time Restricted Eating (TRE) for 8 weeksExperimental Treatment1 Intervention
Participants will receive an intro to TRE and then throughout 8 weeks they will receive brief online psychoeducation several times per week with optional weekly coaching sessions. TRE involves restricting the window of eating to 10 hours/ day, most typically by avoiding eating in the first 1-2 hours after awakening and in the 2-4 before sleep. Those with an eating window > 14 hours will be asked to restrict their eating to 12 hours in the first week, then 10 hours in week 2. To select the period, investigators will ask Ss to review baseline logs to consider sleep, eating, family meals and social commitment schedules, and any special energy demands, such as exercise. During the eating window, no restrictions are placed on the type or quantity of food consumed. The investigators will instruct participants to follow their habitual diet within their 10-hour eating window and to aim to consume the same number of calories per day as they did at baseline.
Group II: Mediterranean diet for 8 weeksActive Control1 Intervention
Participants will receive a several page introduction to the mediterranean diet, and then will receive support throughout the 8 week intervention to follow this food plan, including brief online psychoeducation that will be sent several times per week, and optional weekly coaching sessions. The mediterranean diet is a plan for healthy eating based on how people eat in the mediterranean region. Individuals will be encouraged to consume vegetables (6 servings/day), fruits (2-4 servings/day), whole grains (daily), legumes (3-4 times per week), nuts (.5 oz per day), and oily fish (2 servings/week). Participants will be encouraged to choose lean meats and other sources of protein over red meat and processed meats. Sweets, refined cereals, alcohol, and wine or alcohol will be labelled as extras, and participants will be encouraged to limit consumption of extras.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time restricted eating
2021
N/A
~130

Find a Location

Who is running the clinical trial?

Swinburne University of TechnologyOTHER
21 Previous Clinical Trials
7,568 Total Patients Enrolled
2 Trials studying Bipolar Disorder
452 Patients Enrolled for Bipolar Disorder
Deakin UniversityOTHER
33 Previous Clinical Trials
21,117 Total Patients Enrolled
2 Trials studying Bipolar Disorder
452 Patients Enrolled for Bipolar Disorder
University of California, BerkeleyLead Sponsor
187 Previous Clinical Trials
640,676 Total Patients Enrolled
4 Trials studying Bipolar Disorder
505 Patients Enrolled for Bipolar Disorder
University of British ColumbiaOTHER
1,481 Previous Clinical Trials
2,494,616 Total Patients Enrolled
16 Trials studying Bipolar Disorder
1,578 Patients Enrolled for Bipolar Disorder
Salk Institute for Biological StudiesOTHER
20 Previous Clinical Trials
1,655 Total Patients Enrolled
1 Trials studying Bipolar Disorder
150 Patients Enrolled for Bipolar Disorder
University College, LondonOTHER
863 Previous Clinical Trials
38,752,583 Total Patients Enrolled
2 Trials studying Bipolar Disorder
194 Patients Enrolled for Bipolar Disorder
Wellcome TrustOTHER
220 Previous Clinical Trials
15,687,439 Total Patients Enrolled
1 Trials studying Bipolar Disorder
150 Patients Enrolled for Bipolar Disorder
Sheri L Johnson, PhDPrincipal InvestigatorUniversity of California, Berkeley
1 Previous Clinical Trials
150 Total Patients Enrolled
1 Trials studying Bipolar Disorder
150 Patients Enrolled for Bipolar Disorder
~200 spots leftby Jan 2028